Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study

Journal of Infection

Volumn 62, Issue 2, 2011, Pages 130-135

  Kollef, Marin H ^a   Zilberberg, Marya D ^b,c   Shorr, Andrew F ^d   Vo, Lien ^e   Schein, Jeffrey ^e   Micek, Scott T ^f   Kim, Myoung ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c EviMed Research Group LLC   (United States)

^d WASHINGTON HOSPITAL CENTER   (United States)

^e Ortho McNeil Pharmaceutical Incorporated   (United States)

^f ST LOUIS COLLEGE OF PHARMACY   (United States)

Author keywords

Bacteremia; Community acquired; Healthcare; Outcome

Indexed keywords

ADULT; APACHE; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; COHORT ANALYSIS; COMMUNICABLE DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; ESCHERICHIA COLI; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; PROGNOSIS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADULT; AGED; BACTEREMIA; COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; NURSING HOMES; RENAL DIALYSIS;

EID: 79551588564     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.12.009     Document Type: Article

References (18)

1. Overview of the National Inpatient Sample 2010, Agency for Healthcare Research and Quality, available at, [accessed 12.02.10]. http://www.hcup-us.ahrq.gov/nisoverview.jsp.
2. Kollef M.H., Shorr A., Tabak Y.P., Gupta V., Liu L.Z., Johannes R.S. Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 2005, 128:3854-3862.
3. Micek S.T., Kollef K.E., Reichley R.M., Roubinian N., Kollef M.H. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrobial Agents Chemother 2007, 51:3568-3573.
4. Moran G.J., Krishnadasan A., Gorwitz R.J., Fosheim G.E., McDougal L.K., Carey R.B., et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006, 355:666-674.
5. Zilberberg M.D., Shorr A.F., Micek S.T., Hoban A.P., Pham V., Doherty J.A., et al. Epidemiology and outcomes of hospitalizations with complicated skin and skin-structure infections: implications of healthcare-associated infection risk factors. Infect Control Hosp Epidemiol 2009, 30:1203-1210.
6. Morin C.A., Hadler J.L. Population-based incidence and characteristics of community-onset Staphylococcus aureus infections with bacteremia in 4 metropolitan Connecticut areas, 1998. J Infect Dis 2001, 184:1029-1034.
7. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
8. Siegman-Igra Y., Fourer B., Orni-Wasserlauf R., Golan Y., Noy A., Schwartz D., et al. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infet Dis 2002, 34:1431-1439.
9. Shorr A.F., Tabak Y.P., Killian A.D., Gupta V., Liu L.Z., Kollef M.H. Healthcare-associated bloodstream infection: a distinct entity? Insights from a large US database. Crit Care Med 2006, 34:2588-2595.
10. Carratalà J., Mykietiuk A., Fernández-Sabé N., Suárez C., Dorca J., Verdaguer R., et al. Healthcare-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007, 167:1393-1399.
11. Shindo Y., Sato S., Maruyama E., Ohashi T., Ogawa M., Hashimoto N., et al. Healthcare-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 2009, 135:633-640.
12. Venditti M., Falcone M., Corrao S., Licata G., Serra P. Study group of the Italian Society of Internal Medicine. Outcomes of patients hospitalized with community-acquired, healthcare-associated and hospital-acquired pneumonia. Ann Intern Med 2009, 150:19-26.
13. Iregui M., Ward S., Sherman G., Fraser V.J., Kollef M.H. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262-268.
14. Alvarez-Lerma F. ICU-acquired Pneumonia Study Group. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med 1996, 22:387-394.
15. Zilberberg M.D., Shorr A.F., Micek S.T., Mody S.H., Kollef M.H. Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. Chest 2008, 134:963-968.
16. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416. Hospital-Acquired Pneumonia Guideline Committee of the American Thoracic Society and Infectious Diseases Society of America.
17. McDonald J.R., Friedman N.D., Stout J.E., Sexton D.J., Kaye K.S. Risk factors for ineffective therapy in patients with bloodstream infections. Arch Intern Med 2005, 165:308-313.
18. Ewig S., Welte T., Chastre J., Torres A. Rethinking the concepts of community-acquired and healthcare-associated pneumonia. Lancet Infect Dis 2010, 10:279-287.